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Duke Cameron, MDSEE PAGE 1445M arfan syndrome is the most commoninherited connective tissue disorder inhumans, but has an uncommonly unfa-
vorable natural history (1). Life expectancy is short-
ened by about one-third, usually because of aortic
dissection and rupture in the third decade of life
(2). Over the past 40 years, remarkable progress has
been made to improve the outlook for Marfan syn-
drome patients, and life expectancy is now estimated
to be nearly normal. This has been the result of
earlier clinical recognition of the syndrome in
affected individuals, better imaging of the cardiovas-
cular disease, medical therapy to reduce the rate of
aortic dilation and complications, and ﬁnally prophy-
lactic surgical aortic root replacement in patients
with enlarged aortas at greatest risk of vascular catas-
trophe. The gold standard operation, the so-called
Bentall operation in which the aortic root, ascending
aorta, and valve are replaced with a Dacron pros-
thesis and a prosthetic valve, has established itself
as one of the most effective, safe, reproducible, and
durable operations in cardiac surgery and has saved
countless lives (3).
The Bentall operation typically entails replacement
of the aortic valve, which is often an innocent
bystander of the aortic disease, notwithstanding its
abnormal histological appearance. Replacement of
the valve, although technically simpler and more
expedient than preserving it, introduces a new set of
problems. Mechanical valves mandate a lifetime of
anticoagulation, bioprostheses have limited dura-
bility in young patients, and both types of valves*Editorials published in the Journal of the American College of Cardiology
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to the contents of this paper to disclose.carry a small risk of endocarditis and thromboembo-
lism of 1% to 2% per year, but a signiﬁcant cumulative
lifetime risk.
Since the late 1980s, 2 surgical pioneers, Sir Magdi
Yacoub in the United Kingdom and Tirone David in
Toronto, have championed operations that replace
the aortic root aneurysm with Dacron to prevent
dissection and rupture but preserve the patient’s
valve (4,5). Occasionally valve leaﬂet repairs are
necessary as well to address regurgitation created by
the root aneurysm or by intrinsic leaﬂet abnormal-
ities. These “valve-sparing root replacement” opera-
tions have undergone multiple iterations and in the
current form are known as “David” or “reimplanta-
tion” procedures. Their appeal has been freedom
from the limitations imposed by valve prostheses.
Experience from multiple centers throughout the
world has shown that these operations have an
operative risk similar to the Bentall, as well as
short- and mid-term results on par with those of the
Bentall overall (less thromboembolism, bleeding,
and endocarditis but at the price of a slightly higher
rate of reoperation for late aortic valve incompe-
tence) (6,7).In this issue of the Journal, the paper by David
et al. (8) is a landmark report because of the large
number of Marfan patients who had valve-sparing
surgery (the largest single-institution experience)
and the long-term follow-up. The results are note-
worthy for excellent late survival and a low incidence
of late aortic regurgitation, surgically treated or
otherwise. The report also reminds us of the impor-
tance of late surveillance and clinical monitoring,
as the most common cause of late death remains
distal aortic dissection, and late valve failure remains
an ongoing risk. David also showed us that valve
cusp repair does not hinder long-term success
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1455and that operations that stabilize the annulus
(“reimplantation” procedures) are more durable than
those that do not (“remodeling” procedures).
These are extraordinary outcomes from an experi-
enced master and pioneer surgeon, but can these re-
sults be replicated in other clinical centers by other
surgeons? A multi-institutional study sponsored by
the Marfan Foundation is under way and seeks to
answer this question with a prospective, non-
randomized trial that compares outcomes of valve-
sparing and traditional root replacement surgery in
Marfan patients (9). At present, >300 patients from 19
institutions have been enrolled; approximately 75%have had valve-sparing operations and 25% have
undergone the Bentall procedure. Operative mortality
has been low (0.6%) and similar in the 2 groups, but
there is a concerning 7% incidence of at least mod-
erate regurgitation in the valve-sparing group at 1
year. Until more is known from this and other studies,
the series of David et al. remains a beacon of what is
possible, if not probable.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Duke Cameron, Division of Cardiac Surgery, Zayed 7107,
Johns Hopkins Hospital, 1800 Orleans Street, Baltimore,
Maryland 21287. E-mail: dcameron@jhmi.edu.RE F E RENCE S1. Murdoch JL, Walker BA, Halpern BL, et al.
Life expectancy and causes of death in the
Marfan syndrome. N Engl J Med 1972;286:
804–8.
2. Judge DP, Dietz HC. Marfan’s syndrome. Lancet
2005;366:1965–76.
3. Bentall H, De Bono A. A technique for complete
replacement of the ascending aorta. Thorax 1968;
23:338–9.
4. Yacoub M, Fagan A, Stassano P, et al. Results of
valve conserving operations for aortic regurgita-
tion (abstr). Circulation 1983;68 Suppl III:321.5. David TE, Feindel CM. An aortic valve-
sparing operation for patients with aortic
incompetence and aneurysm of the ascending
aorta. J Thorac Cardiovasc Surg 1992;103:
617–21.
6. Benedetto U, Melina G, Takkenberg JJ, et al.
Surgical management of aortic root disease in
Marfan syndrome: a systematic review and meta-
analysis. Heart 2011;97:955–8.
7. Cameron DE, Alejo DE, Patel ND, et al. Aortic
root replacement in 372 Marfan patients: evolu-
tion of operative repair over 30 years. Ann Thorac
Surg 2009;87:1344–9.8. David TE, David CM, Manlhiot C, Colman J,
Crean AM, Bradley T. Outcomes of aortic valve-
sparing operations in Marfan syndrome. J Am
Coll Cardiol 2015;66:1445–53.
9. Coselli JS, Volguina IV, LeMaire SA. Early and 1-
year outcomes of aortic root surgery in patients
with Marfan syndrome: a prospective, multicenter,
comparative study. J Thor Cardiovasc Surg 2014;
147:1758–66, 1767.e1–4.
KEY WORDS aortic valve, aneurysm,
Marfan syndrome
